Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0022116 (
ischemia
)
91,303
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Hepatocyte growth factor (HGF) is a protective factor in myocardial injury, but its mechanisms of action have not yet been fully elucidated. Nexilin, which locates specifically to the Z-disc, is a novel Z-disc protein that enables the Z-discs to persistently withstand the extreme mechanical forces generated during muscle contraction. Therefore, we investigated the role of HGF in modulating
nexilin
expression in hypoxia-reoxygenation (H/R)-treated cardiomyocytes. We cultured neonatal cardiomyocytes and treated them with HGF. The mRNA and protein levels of
nexilin
were determined by RT-PCR and Western blotting. H/R treatment decreased
nexilin
mRNA expression and
nexilin
protein levels in cardiomyocytes. Furthermore, treatment with HGF upregulated
nexilin
expression and the JNK inhibitor SP600125 partly inhibited HGF-induced
nexilin
upregulation. In conclusion, our results suggest that
ischemia
-reperfusion injury may downregulate
nexilin
expression in cardiomyocytes, and HGF may exert its protective role during myocardial ischemic injury through upregulation of
nexilin
expression in cardiomyocytes.
...
PMID:Hepatocyte growth factor upregulates nexilin gene expression in cardiomyocytes via JNK pathway. 2506 85